Back

The six-minute walk test in transthyretin cardiac amyloidosis - prognostic utility put to the real-world test

30 August 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Sport exercise rehabilitation (3) Exercise ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Christina Kronberger

Medical University of Vienna, Vienna (Austria)

6 More presentations in this session

Presentation thumbnail
Developing a risk assessment system for heart failure during follow-up in acute myocardial infarction patients in combination with cardiopulmonary exercise testing.
Mr H. Cui (Harbin, CN)
Abstract Slides Video
Presentation thumbnail
GRACE score and ischemic and heart failure cardiovascular outcomes in myocardial infarction patients followed in a cardiac rehabilitation program
Doctor V. Marcos Garces (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Clinical significance of vascular ageing patterns and blood pressure responses to submaximal exercise in the community
Mr G. Alanis (Paris, FR)
Abstract Slides Video
Presentation thumbnail
T wave morphology and QRS voltages in adolescents with T wave inversion: relevance for family screening
Doctor M. Abela (Msida, MT)
Abstract Slides Video
Presentation thumbnail
Low yield of genetic testing and predominance of males in athletes with ventricular arrhythmias and non-ischemic left ventricular scar
Doctor F. Graziano (Padova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Sport exercise rehabilitation (3)

The Event

Event poster

ESC Congress 2025

30 August 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic importance of the 6-minute walk test in transthyretin cardiac amyloidosis
thumbnail
Congress Presentation
Assessing functional capacity in patients with ATTR-CM: the role of CPET and 6MWT
thumbnail
Congress Presentation
Decline in functional capacity is associated with reduced ability to perform activities of daily living in patients with transthyretin cardiac amyloidosis: post hoc analysis of the APOLLO-B study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources